<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35807916</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inflammasome Pathway.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2738</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu14132738</ELocationID><Abstract><AbstractText>Black rice is a functional food that is high in anthocyanin content, primarily C3G and P3G. It possesses nutraceutical properties that exhibit a range of beneficial effects on human health. Currently, the spike glycoprotein S1 subunit of SARS-CoV-2 (SP) has been reported for its contribution to pathological inflammatory responses in targeting lung tissue and innate immune cells during COVID-19 infection and in the long-COVID phenomenon. Our objectives focused on the health benefits of the C3G and P3G-rich fraction of black rice germ and bran (BR extract) on the inhibition of inflammatory responses induced by SP, as well as the inhibition of NF-kB activation and the NLRP3 inflammasome pathway in an in vitro model. In this study, BR extract was identified for its active anthocyanins, C3G and P3G, using the HPLC technique. A549-lung cells and differentiated THP-1 macrophages were treated with BR extract, C3G, or P3G prior to exposure to 100 ng/mL of SP. Their anti-inflammatory properties were then determined. BR extract at concentrations of 12.5&#x2212;100 &#x3bc;g/mL exhibited anti-inflammation activity for both A549 and THP-1 cells through the significant suppression of NLRP3, IL-1&#x3b2;, and IL-18 inflammatory gene expressions and IL-6, IL-1&#x3b2;, and IL-18 cytokine secretions in a dose-dependent manner (p &lt; 0.05). It was determined that both cell lines, C3G and P3G (at 1.25&#x2212;10 &#x3bc;g/mL), were compatibly responsible for the significant inhibition of SP-induced inflammatory responses for both gene and protein levels (p &lt; 0.05). With regard to the anti-inflammation mechanism, BR extract, C3G, and P3G could attenuate SP-induced inflammation via counteraction with NF-kB activation and downregulation of the inflammasome-dependent inflammatory pathway proteins (NLRP3, ASC, and capase-1). Overall, the protective effects of anthocyanins obtained from black rice germ and bran can be employed in potentially preventive strategies that use pigmented rice against the long-term sequelae of COVID-19 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Semmarath</LastName><ForeName>Warathit</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-6340-9653</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mapoung</LastName><ForeName>Sariya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4180-1712</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umsumarng</LastName><ForeName>Sonthaya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0275-1188</Identifier><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterinary Biosciences and Veterinary Public Health, Division of Veterinary Preclinical Sciences, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arjsri</LastName><ForeName>Punnida</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6249-4497</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srisawad</LastName><ForeName>Kamonwan</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0260-7215</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thippraphan</LastName><ForeName>Pilaiporn</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yodkeeree</LastName><ForeName>Supachai</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9023-2283</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dejkriengkraikul</LastName><ForeName>Pornngarm</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8732-8911</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FF65/025</GrantID><Agency>The Fundamental Fund 2022, Chiang Mai University</Agency><Country/></Grant><Grant><GrantID>PHD/0126/2559</GrantID><Agency>The Royal Golden Jubilee Scholarship PhD. Program (RGJ)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000872">Anthocyanins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005960">Glucosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020382">Interleukin-18</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>3419IIT8I0</RegistryNumber><NameOfSubstance UI="C480521">peonidin 3-glucoside</NameOfSubstance></Chemical><Chemical><RegistryNumber>7732ZHU564</RegistryNumber><NameOfSubstance UI="C017154">cyanidin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000872" MajorTopicYN="N">Anthocyanins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005960" MajorTopicYN="N">Glucosides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020382" MajorTopicYN="N">Interleukin-18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012275" MajorTopicYN="Y">Oryza</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C3G</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">NLRP3 inflammasome</Keyword><Keyword MajorTopicYN="N">P3G</Keyword><Keyword MajorTopicYN="N">anthocyanins</Keyword><Keyword MajorTopicYN="N">anti-inflammation</Keyword><Keyword MajorTopicYN="N">black rice</Keyword><Keyword MajorTopicYN="N">post-acute COVID</Keyword><Keyword MajorTopicYN="N">spike glycoprotein S1</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35807916</ArticleId><ArticleId IdType="pmc">PMC9268823</ArticleId><ArticleId IdType="doi">10.3390/nu14132738</ArticleId><ArticleId IdType="pii">nu14132738</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conti P., Ronconi G., Caraffa A., Gallenga C., Ross R., Frydas I., Kritas S. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents. 2020;34:327&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">32171193</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid&#x2014;Mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder J.T., Bieneman A.P. The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3. Front. Immunol. 2022;13:831763. doi: 10.3389/fimmu.2022.831763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.831763</ArticleId><ArticleId IdType="pmc">PMC8982143</ArticleId><ArticleId IdType="pubmed">35392091</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N., Britton G.J., Gruber C., Hegde S., Kim J., Kuksin M., Levantovsky R., Malle L., Moreira A., Park M.D. Immunology of COVID-19: Current state of the science. Immunity. 2020;52:910&#x2013;941. doi: 10.1016/j.immuni.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K., Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021;7:e06187. doi: 10.1016/j.heliyon.2021.e06187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e06187</ArticleId><ArticleId IdType="pmc">PMC7887388</ArticleId><ArticleId IdType="pubmed">33644468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Shafiei M.S., Longoria C., Schoggins J.W., Savani R.C., Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-&#x3ba;B pathway. Elife. 2021;10:68563. doi: 10.7554/eLife.68563.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Barhoumi T., Alghanem B., Shaibah H., Mansour F.A., Alamri H.S., Akiel M.A., Alroqi F., Boudjelal M. SARS-CoV-2 coronavirus spike protein-induced apoptosis, inflammatory, and oxidative stress responses in THP-1-like-macrophages: Potential role of angiotensin-converting enzyme inhibitor (perindopril) Front. Immunol. 2021;12:728896. doi: 10.3389/fimmu.2021.728896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.728896</ArticleId><ArticleId IdType="pmc">PMC8488399</ArticleId><ArticleId IdType="pubmed">34616396</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol. Neurobiol. 2022;59:1850&#x2013;1861. doi: 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J. Med. Virol. 2020;92:2105&#x2013;2113. doi: 10.1002/jmv.25987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25987</ArticleId><ArticleId IdType="pmc">PMC7267663</ArticleId><ArticleId IdType="pubmed">32383269</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosch S.F., Mahajan S.D., Collins A.R. SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-&#x3ba;B pathway in human monocyte macrophages in vitro. Virus Res. 2009;142:19&#x2013;27. doi: 10.1016/j.virusres.2009.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2009.01.005</ArticleId><ArticleId IdType="pmc">PMC2699111</ArticleId><ArticleId IdType="pubmed">19185596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak M.Z., Kucia M. SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine &#x201c;storm&#x201d; and risk factor for damage of hematopoietic stem cells. Leukemia. 2020;34:1726&#x2013;1729. doi: 10.1038/s41375-020-0887-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-020-0887-9</ArticleId><ArticleId IdType="pmc">PMC7262681</ArticleId><ArticleId IdType="pubmed">32483300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H., Min D.S., Park H., Kim H.P. Flavonoids interfere with NLRP3 inflammasome activation. Toxicol. Appl. Pharmacol. 2018;355:93&#x2013;102. doi: 10.1016/j.taap.2018.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2018.06.022</ArticleId><ArticleId IdType="pubmed">29960001</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmarath W., Seesen M., Yodkeeree S., Sapbamrer R., Ayood P., Malasao R., Siviroj P., Limtrakul P. The association between frailty indicators and blood-based biomarkers in early-old community dwellers of Thailand. Int. J. Environ. Res. Public Health. 2019;16:3457. doi: 10.3390/ijerph16183457.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16183457</ArticleId><ArticleId IdType="pmc">PMC6765843</ArticleId><ArticleId IdType="pubmed">31533354</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Sanhueza D., Inostroza-Blancheteau C., Ribera-Fonseca A., Reyes-D&#xed;az M. Superfood and Functional Food&#x2014;The Development of Superfoods and Their Roles as Medicine. IntechOpen; London, UK: 2017. Anthocyanins in berries and their potential use in human health; pp. 155&#x2013;172.</Citation></Reference><Reference><Citation>Samyor D., Das A.B., Deka S.C. Pigmented rice a potential source of bioactive compounds: A review. Int. J. Food Sci. Technol. 2017;52:1073&#x2013;1081. doi: 10.1111/ijfs.13378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijfs.13378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohail M., Rakha A., Butt M.S., Iqbal M.J., Rashid S. Rice bran nutraceutics: A comprehensive review. Crit. Rev. Food Sci. Nutr. 2017;57:3771&#x2013;3780. doi: 10.1080/10408398.2016.1164120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2016.1164120</ArticleId><ArticleId IdType="pubmed">27015585</ArticleId></ArticleIdList></Reference><Reference><Citation>Limtrakul P., Semmarath W., Mapoung S. Anthocyanins and proanthocyanidins in natural pigmented rice and their bioactivities. Phytochem. Hum. Health. 2019;1:86962.</Citation></Reference><Reference><Citation>Dias A.L.d.S., Pachikian B., Larondelle Y., Quetin-Leclercq J. Recent advances on bioactivities of black rice. Curr. Opin. Clin. Nutr. Metab. Care. 2017;20:470&#x2013;476. doi: 10.1097/MCO.0000000000000417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000417</ArticleId><ArticleId IdType="pubmed">28858891</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Zhang Z.-S., Zhang X.-H., Yang S.-N., Liu D., Diao C.-R., Wang H., Zheng F.-P. Cyanidin inhibits EMT induced by oxaliplatin via targeting the PDK1&#x2013;PI3K/Akt signaling pathway. Food Funct. 2019;10:592&#x2013;601. doi: 10.1039/C8FO01611A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8FO01611A</ArticleId><ArticleId IdType="pubmed">30672917</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M.W., Zhang R.F., Zhang F.X., Liu R.H. Phenolic profiles and antioxidant activity of black rice bran of different commercially available varieties. J. Agric. Food Chem. 2010;58:7580&#x2013;7587. doi: 10.1021/jf1007665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf1007665</ArticleId><ArticleId IdType="pubmed">20521821</ArticleId></ArticleIdList></Reference><Reference><Citation>Limtrakul P., Yodkeeree S., Pitchakarn P., Punfa W. Suppression of inflammatory responses by black rice extract in RAW 264.7 macrophage cells via downregulation of NF-kB and AP-1 signaling pathways. Asian Pac. J. Cancer Prev. 2015;16:4277&#x2013;4283. doi: 10.7314/APJCP.2015.16.10.4277.</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2015.16.10.4277</ArticleId><ArticleId IdType="pubmed">26028086</ArticleId></ArticleIdList></Reference><Reference><Citation>Seesen M., Semmarath W., Yodkeeree S., Sapbamrer R., Ayood P., Malasao R., Ongprasert K., Chittrakul J., Siviroj P. Combined black rice germ, bran supplement and exercise intervention modulate aging biomarkers and improve physical performance and lower-body muscle strength parameters in aging population. Int. J. Environ. Res. Public Health. 2020;17:2931. doi: 10.3390/ijerph17082931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17082931</ArticleId><ArticleId IdType="pmc">PMC7215642</ArticleId><ArticleId IdType="pubmed">32340343</ArticleId></ArticleIdList></Reference><Reference><Citation>Messaoudi O., Gouzi H., El-Hoshoudy A.N., Benaceur F., Patel C., Goswami D., Boukerouis D., Bendahou M. Berries anthocyanins as potential SARS-CoV&#x2013;2 inhibitors targeting the viral attachment and replication; molecular docking simulation. Egypt J. Pet. 2021;30:33&#x2013;43. doi: 10.1016/j.ejpe.2021.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpe.2021.01.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalifa I., Nawaz A., Sobhy R., Althwab S.A., Barakat H. Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CLpro of 2019-nCoV than monomeric anthocyanins: A structural-relationship activity study with 10 anthocyanins using in-silico approaches. J. Mol. Graph. Model. 2020;100:107690. doi: 10.1016/j.jmgm.2020.107690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2020.107690</ArticleId><ArticleId IdType="pmc">PMC7380243</ArticleId><ArticleId IdType="pubmed">32745925</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Rangel J.C., Benavides J., Heredia J.B., Cisneros-Zevallos L., Jacobo-Vel&#xe1;zquez D.A. The Folin&#x2013;Ciocalteu assay revisited: Improvement of its specificity for total phenolic content determination. Anal. Methods. 2013;5:5990&#x2013;5999. doi: 10.1039/c3ay41125g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3ay41125g</ArticleId></ArticleIdList></Reference><Reference><Citation>Yodkeeree S., Thippraphan P., Punfa W., Srisomboon J., Limtrakul P. Skin anti-aging assays of proanthocyanidin rich red rice extract, oryzanol and other phenolic compounds. Nat. Prod. Commun. 2018;13:967&#x2013;972. doi: 10.1177/1934578X1801300812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1934578X1801300812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Durst R.W., Wrolstad R.E. Determination of total monomeric anthocyanin pigment content of fruit juices, beverages, natural colorants, and wines by the pH differential method: Collaborative study. J. AOAC Int. 2005;88:1269&#x2013;1278. doi: 10.1093/jaoac/88.5.1269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jaoac/88.5.1269</ArticleId><ArticleId IdType="pubmed">16385975</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan V., Rani R., Pushkar S., Lal S., Srivastava S., Kumari S., Vinutha T., Dahuja A., Praveen S., Sachdev A. Anthocyanin fingerprinting and dynamics in differentially pigmented exotic soybean genotypes using modified HPLC&#x2013;DAD method. J. Food Meas. Charact. 2020;14:1966&#x2013;1975. doi: 10.1007/s11694-020-00443-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11694-020-00443-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Ma L., Cai C., Gong X. Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK/NF-&#x3ba;B and A2aR signaling in LPS-Induced THP-1 macrophages. Int. J. Biol. Sci. 2019;15:1571&#x2013;1581. doi: 10.7150/ijbs.34211.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.34211</ArticleId><ArticleId IdType="pmc">PMC6643212</ArticleId><ArticleId IdType="pubmed">31360100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Wang C., Wu W., Liu T., Ji B., Zhou F. Cyanidin-3-glucoside alleviates 4-hydroxyhexenal-induced NLRP3 inflammasome activation via JNK-c-Jun/AP-1 pathway in human retinal pigment epithelial cells. J. Immunol. Res. 2018;2018:5604610. doi: 10.1155/2018/5604610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5604610</ArticleId><ArticleId IdType="pmc">PMC5952446</ArticleId><ArticleId IdType="pubmed">29854843</ArticleId></ArticleIdList></Reference><Reference><Citation>Paramel Varghese G., Folkersen L., Strawbridge R.J., Halvorsen B., Yndestad A., Ranheim T., Krohg-S&#xf8;rensen K., Skjelland M., Espevik T., Aukrust P. NLRP 3 inflammasome expression and activation in human atherosclerosis. J. Am. Heart Assoc. 2016;5:e003031. doi: 10.1161/JAHA.115.003031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.003031</ArticleId><ArticleId IdType="pmc">PMC4889178</ArticleId><ArticleId IdType="pubmed">27207962</ArticleId></ArticleIdList></Reference><Reference><Citation>Mapoung S., Umsumarng S., Semmarath W., Arjsri P., Srisawad K., Thippraphan P., Yodkeeree S., Dejkriengkraikul P. Photoprotective Effects of a Hyperoside-Enriched Fraction Prepared from Houttuynia cordata Thunb. on Ultraviolet B-Induced Skin Aging in Human Fibroblasts through the MAPK Signaling Pathway. Plants. 2021;10:2628. doi: 10.3390/plants10122628.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/plants10122628</ArticleId><ArticleId IdType="pmc">PMC8708340</ArticleId><ArticleId IdType="pubmed">34961096</ArticleId></ArticleIdList></Reference><Reference><Citation>Yodkeeree S., Pompimon W., Limtrakul P. Crebanine, an aporphine alkaloid, sensitizes TNF-&#x3b1;-induced apoptosis and suppressed invasion of human lung adenocarcinoma cells A549 by blocking NF-&#x3ba;B-regulated gene products. Tumor Biol. 2014;35:8615&#x2013;8624. doi: 10.1007/s13277-014-1998-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-014-1998-6</ArticleId><ArticleId IdType="pubmed">24867094</ArticleId></ArticleIdList></Reference><Reference><Citation>Barilli A., Visigalli R., Ferrari F., Bianchi M.G., Dall&#x2019;Asta V., Rotoli B.M. Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology. Biomedicines. 2022;10:618. doi: 10.3390/biomedicines10030618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030618</ArticleId><ArticleId IdType="pmc">PMC8945544</ArticleId><ArticleId IdType="pubmed">35327420</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q., Wu X., Zheng X., Luo S., Xu S., Weng J. Targeting inflammation and cytokine storm in COVID-19. Pharmacol. Res. 2020;159:105051. doi: 10.1016/j.phrs.2020.105051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105051</ArticleId><ArticleId IdType="pmc">PMC7320704</ArticleId><ArticleId IdType="pubmed">32603772</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang L., Joo D., Sun S.-C. NF-&#x3ba;B signaling in inflammation. Signal. Transduct. Target. Ther. 2017;2:17023. doi: 10.1038/sigtrans.2017.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi-Boroujeni A., Mahmoudian-Sani M.R., Bahadoram M., Alghasi A. COVID-19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin? Basic Clin. Pharmacol. Toxicol. 2021;128:37&#x2013;45. doi: 10.1111/bcpt.13503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcpt.13503</ArticleId><ArticleId IdType="pubmed">33099890</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman T.L., Swartz T.H. Targeting the NLRP3 inflammasome in severe COVID-19. Front. Immunol. 2020;11:1518. doi: 10.3389/fimmu.2020.01518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01518</ArticleId><ArticleId IdType="pmc">PMC7324760</ArticleId><ArticleId IdType="pubmed">32655582</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Martin J.C. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat. Rev. Immunol. 2020;20:355&#x2013;362. doi: 10.1038/s41577-020-0331-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Shin E.-C. The type I interferon response in COVID-19: Implications for treatment. Nat. Rev. Immunol. 2020;20:585&#x2013;586. doi: 10.1038/s41577-020-00429-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00429-3</ArticleId><ArticleId IdType="pmc">PMC8824445</ArticleId><ArticleId IdType="pubmed">32788708</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H., Lou F., Fan J., Li M., Tong Y. The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era. Lancet Microbe. 2022;3:1. doi: 10.1016/S2666-5247(21)00278-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00278-0</ArticleId><ArticleId IdType="pmc">PMC8616564</ArticleId><ArticleId IdType="pubmed">34849495</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo M., Moccia S., Spagnuolo C., Tedesco I., Russo G.L. Roles of flavonoids against coronavirus infection. Chem. Biol. Interact. 2020;328:109211. doi: 10.1016/j.cbi.2020.109211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2020.109211</ArticleId><ArticleId IdType="pmc">PMC7385538</ArticleId><ArticleId IdType="pubmed">32735799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L.H., Jiang Y.-M., Shi J., Tomas-Barberan F., Datta N., Singanusong R., Chen S. Flavonoids in food and their health benefits. Plant. Foods Hum. Nutr. 2004;59:113&#x2013;122. doi: 10.1007/s11130-004-0049-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11130-004-0049-7</ArticleId><ArticleId IdType="pubmed">15678717</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A., Sarkar A., Maulik U. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci. Rep. 2020;10:17699. doi: 10.1038/s41598-020-74715-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74715-4</ArticleId><ArticleId IdType="pmc">PMC7573581</ArticleId><ArticleId IdType="pubmed">33077836</ArticleId></ArticleIdList></Reference><Reference><Citation>Shawan M.M.A.K., Halder S.K., Hasan M.A. Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: An in silico molecular modeling approach in battling the COVID-19 outbreak. Bull. Natl. Res. Cent. 2021;45:27. doi: 10.1186/s42269-020-00479-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42269-020-00479-6</ArticleId><ArticleId IdType="pmc">PMC7816153</ArticleId><ArticleId IdType="pubmed">33495684</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams C.A., Grayer R.J. Anthocyanins and other flavonoids. Nat. Prod. Rep. 2004;21:539&#x2013;573. doi: 10.1039/b311404j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b311404j</ArticleId><ArticleId IdType="pubmed">15282635</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Shao Y., Bao J., Beta T. Phenolic compounds and antioxidant properties of breeding lines between the white and black rice. Food Chem. 2015;172:630&#x2013;639. doi: 10.1016/j.foodchem.2014.09.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2014.09.118</ArticleId><ArticleId IdType="pubmed">25442600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratheeshkumar P., Son Y.-O., Wang X., Divya S.P., Joseph B., Hitron J.A., Wang L., Kim D., Yin Y., Roy R.V. Cyanidin-3-glucoside inhibits UVB-induced oxidative damage and inflammation by regulating MAP kinase and NF-&#x3ba;B signaling pathways in SKH-1 hairless mice skin. Toxicol. Appl. Pharmacol. 2014;280:127&#x2013;137. doi: 10.1016/j.taap.2014.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2014.06.028</ArticleId><ArticleId IdType="pmc">PMC4330564</ArticleId><ArticleId IdType="pubmed">25062774</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X.Q., Nagao N., Itani T., Irifune K. Anti-oxidative analysis, and identification and quantification of anthocyanin pigments in different coloured rice. Food Chem. 2012;135:2783&#x2013;2788. doi: 10.1016/j.foodchem.2012.06.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2012.06.098</ArticleId><ArticleId IdType="pubmed">22980872</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Luna-Vital D., de Mejia E.G. Anthocyanins from colored maize ameliorated the inflammatory paracrine interplay between macrophages and adipocytes through regulation of NF-&#x3ba;B and JNK-dependent MAPK pathways. J. Funct. Foods. 2019;54:175&#x2013;186. doi: 10.1016/j.jff.2019.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2019.01.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Olajide O.A., Iwuanyanwu V.U., Lepiarz-Raba I., Al-Hindawi A.A. Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a recombinant SARS-CoV-2 spike glycoprotein S1 and its inhibition by dexamethasone. Inflammation. 2021;44:1865&#x2013;1877. doi: 10.1007/s10753-021-01464-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-021-01464-5</ArticleId><ArticleId IdType="pmc">PMC8050229</ArticleId><ArticleId IdType="pubmed">33860869</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboudounya M.M., Heads R.J. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediat. Inflamm. 2021;2021:8874339. doi: 10.1155/2021/8874339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8874339</ArticleId><ArticleId IdType="pmc">PMC7811571</ArticleId><ArticleId IdType="pubmed">33505220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn K.M., Lee S.-G., Kim H.J., Cheon S., Jeong H., Lee J., Kim I.S., Silwal P., Kim Y.J., Paik S. COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis. J. Korean Med. Sci. 2020;35:e343. doi: 10.3346/jkms.2020.35.e343.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e343</ArticleId><ArticleId IdType="pmc">PMC7521960</ArticleId><ArticleId IdType="pubmed">32989935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Zhao Y., Zhang F., Wang Q., Li T., Liu Z., Wang J., Qin Y., Zhang X., Yan X. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. J. Clin. Immunol. 2020;214:108393. doi: 10.1016/j.clim.2020.108393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108393</ArticleId><ArticleId IdType="pmc">PMC7102614</ArticleId><ArticleId IdType="pubmed">32222466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Lin H., Xie S., Huang B., Qian Y., Chen K., Niu Y., Shen H.-M., Cai J., Li P. Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination. Toxicol. Appl. Pharmacol. 2019;365:19&#x2013;29. doi: 10.1016/j.taap.2018.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2018.12.019</ArticleId><ArticleId IdType="pubmed">30594691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J., Xie X., Feng X.-L., Xu L., Han J.-B., Yu D., Zou Q.-C., Liu Q., Li X., Ma G. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice. EBioMedicine. 2022;75:103803. doi: 10.1016/j.ebiom.2021.103803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103803</ArticleId><ArticleId IdType="pmc">PMC8719059</ArticleId><ArticleId IdType="pubmed">34979342</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson J.G., Simpson L.J., Ferreira A.-M., Rustagi A., Roque J., Asuni A., Ranganath T., Grant P.M., Subramanian A., Rosenberg-Hasson Y. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight. 2020;5:e140289. doi: 10.1172/jci.insight.140289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140289</ArticleId><ArticleId IdType="pmc">PMC7526438</ArticleId><ArticleId IdType="pubmed">32706339</ArticleId></ArticleIdList></Reference><Reference><Citation>Molagoda I.M.N., Lee K.T., Choi Y.H., Jayasingha J.A.C.C., Kim G.-Y. Anthocyanins from Hibiscus syriacus L. inhibit NLRP3 inflammasome in BV2 microglia cells by alleviating NF-&#x3ba;B-and ER stress-induced Ca2+ accumulation and mitochondrial ROS production. Oxid. Med. Cell. Longev. 2021;2021:1246491. doi: 10.1155/2021/1246491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/1246491</ArticleId><ArticleId IdType="pmc">PMC7878077</ArticleId><ArticleId IdType="pubmed">33613822</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Lin X., Zhang P., Liu Y., Ling W., Guo H. Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study. Clin. Res. Hepatol. Gastroenterol. 2022;46:101843. doi: 10.1016/j.clinre.2021.101843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinre.2021.101843</ArticleId><ArticleId IdType="pubmed">34922061</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva G.K., Costa R.S., Silveira T.N., Caetano B.C., Horta C.V., Gutierrez F.R.S., da Matta Guedes P.M., Andrade W.A., De Niz M., Gazzinelli R.T. Apoptosis-associated Speck&#x2013;like protein containing a caspase recruitment domain inflammasomes mediate IL-1&#x3b2; response and host resistance to Trypanosoma cruzi infection. J. Immunol. 2013;191:3373&#x2013;3383. doi: 10.4049/jimmunol.1203293.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1203293</ArticleId><ArticleId IdType="pubmed">23966627</ArticleId></ArticleIdList></Reference><Reference><Citation>Groslambert M., Py B.F. Spotlight on the NLRP3 inflammasome pathway. J. Inflamm. Res. 2018;11:359&#x2013;374. doi: 10.2147/JIR.S141220.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S141220</ArticleId><ArticleId IdType="pmc">PMC6161739</ArticleId><ArticleId IdType="pubmed">30288079</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra R., Das N.C., Mukherjee S. Targeting human TLRs to combat COVID-19: A solution? J. Med. Virol. 2021;93:615&#x2013;617. doi: 10.1002/jmv.26387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26387</ArticleId><ArticleId IdType="pmc">PMC7436140</ArticleId><ArticleId IdType="pubmed">32749702</ArticleId></ArticleIdList></Reference><Reference><Citation>Paladino L., Vitale A.M., Caruso Bavisotto C., Conway de Macario E., Cappello F., Macario A.J., Marino Gammazza A. The role of molecular chaperones in virus infection and implications for understanding and treating COVID-19. J. Clin. Med. 2020;9:3518. doi: 10.3390/jcm9113518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9113518</ArticleId><ArticleId IdType="pmc">PMC7693988</ArticleId><ArticleId IdType="pubmed">33143379</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>